CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice

Aptar Stelmi will showcase PremiumCoat™, the alternative coated stopper for sensitive drugs, at CPhI India from November 21 to 23, in Mumbai, India

stelmi1
stelmi2

PremiumCoat™, the alternative coated stopper for sensitive drugs

PremiumCoat™ is a novel range of elastomeric stoppers developed by Aptar Stelmi and based on an approved, pure, state-of-the-art formulation. The surface of the elastomer is coated during manufacturing with a thin fluoropolymer film. This coating acts as an effective barrier to many of the extractables and leachables that can be released from the elastomer. As a result, compatibility of the drug and the closure is significantly superior.
The first design to be released in 2015 was a 20 mm coated stopper. We are widening our PremiumCoat™ range introducing a 13 mm coated stopper, and will soon extend our offer with other products.
 

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026